Latest filing published 13 Jan 2025 for Cartesian Therapeutics, Inc., €28k.
Filing timeline
BuySaleInsider track record
Christopher M. Jewell: trading record in brief
Christopher M. Jewell appears in our data through filings on Cartesian Therapeutics, Inc. shares, published by SEC (Form 4). We count 11 filings; the first trade dates from 2 January 2024 and the latest from 10 January 2025.
No open-market purchase appears, only 5 sales worth €871k. Other entries cover 2 share grants and 4 option exercises. So far in 2025, the count stands at no purchases and 2 sales.
Most recently, on 13 January 2025, the filings show an option exercise worth €28k in Cartesian Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher M. Jewell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,000 shares@ US$3.2314.0% of flowCommon StockSEC:0001453687-25-000045:0
- 1,264 shares@ US$16.721910.2% of flowCommon StockSEC:0001453687-25-000038:0
- 16,100 shares0Common StockSEC:0001453687-25-000027:0
- 14,000 shares@ US$3.2321.1% of flowCommon StockSEC:0001453687-24-000138:0
- 36,050 shares@ US$3.2354.7% of flowCommon StockSEC:0001453687-24-000128:0
- 778,200 shares0Common StockSEC:0001453687-24-000026:0
6 of 6 declarations
